Seiwerth Jasmin, Tasiopoulou Georgia, Hoffmann Julia, Wölfle Ute, Schwabe Kay, Quirin Karl-Werner, Schempp Christoph Mathis
Research Center skinitial, Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany.
BSI Beauty Science Intelligence GmbH, Langenhagen, Germany.
Planta Med. 2019 May;85(7):608-614. doi: 10.1055/a-0835-6806. Epub 2019 Jan 28.
The anti-inflammatory properties of the topical herbal composition VEL-091604 with gentian root, licorice root, and willow bark extract were assessed in a randomized, prospective, placebo-controlled, double-blind ultraviolet (UV)-erythema test study with 42 healthy volunteers in comparison to 1% hydrocortisone acetate. The efficacy and tolerability of VEL-091604 cream 2 times daily over 2 wk was evaluated in an open-label, prospective proof of concept study in 10 subjects with atopic dermatitis using a lesional SCORAD severity score. In the UV-erythema test VEL-091604 cream significantly reduced inflammation compared to placebo and was as effective as 1% hydrocortisone acetate. The clinical study with atopic subjects revealed a significant and rapid reduction of the lesional SCORAD severity score in the test areas after 1 and 2 wk. No adverse events were recorded. It is concluded that the herbal cream VEL-091604 with licorice root, willow bark, and gentian root extract display anti-inflammatory properties . It is a promising new treatment option for atopic dermatitis that warrants further investigation in controlled studies.
在一项随机、前瞻性、安慰剂对照、双盲的紫外线(UV)红斑试验研究中,对42名健康志愿者使用含龙胆根、甘草根和柳树皮提取物的外用草药组合物VEL - 091604的抗炎特性进行了评估,并与1%醋酸氢化可的松进行比较。在一项开放标签、前瞻性概念验证研究中,对10名特应性皮炎患者使用皮损SCORAD严重程度评分,评估了每天2次、持续2周使用VEL - 091604乳膏的疗效和耐受性。在紫外线红斑试验中,与安慰剂相比,VEL - 091604乳膏显著减轻了炎症,且与1%醋酸氢化可的松效果相当。对特应性受试者的临床研究显示,在1周和2周后,试验区域的皮损SCORAD严重程度评分显著且迅速降低。未记录到不良事件。结论是,含甘草根、柳树皮和龙胆根提取物的草药乳膏VEL - 091604具有抗炎特性。它是特应性皮炎一种有前景的新治疗选择,值得在对照研究中进一步研究。